The central hypothesis of this application is that growth regulating pathways expressed in human and mouse alveolar type II cell pulmonary adenocarcinomas (PAC type II) and in human and hamster pulmonary squamous cell carcinomas (SQCs) are antagonistic to those expressed in human and hamster Clara cell type pulmonary adenocarcinomas (PACCs). Chemoprevention studies applicable to former smokers therefore need to use models representing these differently regulated cancer types. Non-invasive methods need to be developed that allow to monitor the expression levels of these pathways in former smokers to asses response to treatment and to ensure assignment of individuals to effective chemopreventive treatments while avoiding potentially cancer promoting agents. To achieve these goals in a preclinical setup, our specific aims are as follows: 1) We will characterize the effects of green tea, theophylline, beta-carotene, retinol, glucocorticoid beta- blockers, cAMP antaogonists, and inhibitors of cyclooxygenase-2 (COX-2) or 5-1ipooxygenase (5-.LOX) in human lung cancer cell lines derived from PAC type II, PACC or QSQC and in non-tumorigenic and tumorigenic mouse PAC type II cell lines. 2) We will synthesize iodine-125 and -123-labeled analogues of inhibitors of COX-2, cAMP-dependent PKA and 5-LOX for use in micro-photon emisssion tomography (micro-SPECT). We will verify the binding of these analogues to their cellular targets by in vitro binding assays, using human lung cancer cell lines characterized under aim 1 and by in vivo bio-distribution studies, using mice carrying xenographs of these human lung cancer cell lines. 3) We will study the chemopreventive effects of selected agents from aim 1 in bioassay experiments, using the A/J/mouse PAC type II model, the hamster PACC model and the hamster SQC model. The experimental designs will simulate chemoprevention in former smokers by starting the chemopreventive treatments at the time when tumor induction treatment has been discontinued and precancerous lesions are present in the animals. Evaluation of data will include histopathology, including immunostains for COX-2, PKA and 5-LOX as well as analysis of protein expression of these enzymes by Western blots in normal cells of origin of the induced tumors, premalignant lesions, and in lung cancers harvested by laser capture microscopy. 4) Using the iodine-125-1abeled analogues from aim 2, we will conduct micro-SPECT analysis of five randomly chosen animals per treatment group of aim 3 before, during and after completion of chemopreventive treatments and we will attempt to quantitate levels of COX-2, PKA, and 5-LOX in lung tissues and lung tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA096128-01A1
Application #
6613046
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (J2))
Program Officer
Steele, Vernon E
Project Start
2003-05-01
Project End
2006-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
1
Fiscal Year
2003
Total Cost
$289,600
Indirect Cost
Name
University of Tennessee Knoxville
Department
Pathology
Type
Schools of Veterinary Medicine
DUNS #
003387891
City
Knoxville
State
TN
Country
United States
Zip Code
37996
Schuller, Hildegard M (2013) Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: implications for intervention. Cancer Biomark 13:133-44
Al-Wadei, Hussein A N; Schuller, Hildegard M (2009) Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas. J Pathol 218:437-45
Al-Wadei, Hussein A N; Schuller, Hildegard M (2009) Non-genomic inhibitory signaling of beta-carotene in squamous cell carcinoma of the lungs. Int J Oncol 34:1093-8
Al-Wadei, Hussein A N; Schuller, Hildegard M (2009) beta-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma. Eur J Cancer 45:1257-64
Schuller, Hildegard M; Al-Wadei, Hussein A N; Majidi, Mourad (2008) Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 29:1979-85
Schuller, Hildegard M (2008) Neurotransmission and cancer: implications for prevention and therapy. Anticancer Drugs 19:655-71
Schuller, Hildegard M (2007) Nitrosamines as nicotinic receptor ligands. Life Sci 80:2274-80
Cekanova, Maria; Majidy, Mourad; Masi, Thomas et al. (2007) Overexpressed Raf-1 and phosphorylated cyclic adenosine 3'-5'-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Cancer 109:1164-73
Majidi, Mourad; Al-Wadei, Hussein A; Takahashi, Takashi et al. (2007) Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells. Cancer Res 67:6863-71
Al-Wadei, Hussein A N; Takahashi, Takashi; Schuller, Hildegard M (2006) Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer 118:1370-80

Showing the most recent 10 out of 21 publications